56 The most common adverse events were gastrointestinal in the preclinical, phase1 and 2 trials similar to trials involving injectable GLP-1 agonists
These medications mimic the effects of a hormone called glucagon-like peptide-1 (GLP-1) in the body
03 Treatment Initiation & Education If you qualify and choose to move forward, your care team reviews medication education, injection technique, dose titration, nutrition priorities, and lifestyle modifications
It also helps reduce oxidative stress and inflammation in the body
Do not store in pill organizers or open containers
If denied, discuss compounding pharmacy alternatives with your healthcare provider, as 503A compounded options may bypass quantity restrictions while maintaining therapeutic efficacy under medical supervision